Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

ClinicalTrials.gov ID: NCT07441252

Public ClinicalTrials.gov record NCT07441252. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2b Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety and Tolerability of Maridebart Cafraglutide in Adult Participants Living With Elevated Liver Fat and Obesity or Overweight

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main objective of this trial will be to determine whether maridebart cafraglutide is superior to placebo on reduction in liver fat content and body weight in participants living with obesity or overweight and elevated liver fat content, when administered in conjunction with reduced-calorie diet and increased physical activity.

Study identification

NCT ID
NCT07441252
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
180 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 5, 2026 (Actual)
Primary completion
Aug 25, 2027 (Estimated)
Completion
Nov 17, 2027 (Estimated)
Last update posted
Sep 28, 2026

2026 – 2027

United States locations

U.S. sites
23
U.S. states
8
U.S. cities
20
Facility City State ZIP Site status
Arizona Clinical Trials Chandler Arizona 85224 —
Medical Advancement Centers of Arizona Phoenix Arizona 85044 —
Del Sol Research Management Tucson Arizona 85715 —
San Fernando Valley Health Institute Canoga Park California 91304 —
Gastroenterology and Liver Institute Escondido California 92025 —
Inland Empire Liver Foundation Rialto California 92377 —
Apex Clinical Research San Diego California 92120 —
University of Florida College of Medicine-Jacksonville Gainesville Florida 32610 —
Floridian Clinical Research LLC Miami Lakes Florida 33016 —
Indago Research and Health Center Miami Lakes Florida 33016 —
Gastrointestinal Specialists- Louisiana Research Center- Highland Shreveport Louisiana 71105 —
Woodholme Gastroenterology Associates - Glen Burnie Glen Burnie Maryland 21061 —
Alliance for Multispecialty Research - Kansas City Kansas City Missouri 64114 —
Excel Clinical Research Las Vegas Nevada 89109 —
Bellaire Clinical Research Bellaire Texas 77401 —
Juno Research LLC Bellaire Texas 77401 —
Pinnacle Clinical Research - Corpus Christi Corpus Christi Texas 78404 —
South Texas Research Institute Edinburg Texas 78539 —
Houston Research Institute Houston Texas 77079 —
Houston Research Institute - Pasadena Pasadena Texas 77505 —
McAllen Research Pharr Texas 78557 —
American Research Corporation at the Texas Liver Institute San Antonio Texas 78215 —
Pinnacle Clinical Research San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07441252, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 28, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07441252 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →